Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease-Reference-Cited by-同舟云学术

Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease

Published:2022-05 Issue:5 Volume:128 Page:575-582
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Mullur Jyotsna,Steger Camille M.,Gakpo Deborah,Bensko Jillian C.,Maurer Rie,Laidlaw Tanya M.,Buchheit Kathleen M.

Funder

National Institutes of Health

Regeneron Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference24 articles.

1. Aspirin-exacerbated respiratory disease: association between patient-reported sinus and asthma morbidity;Bergmark;J Allergy Clin Immunol Pract,2021

2. The Burden of Non-steroidal anti-inflammatory exacerbated respiratory disease from the patient’s perspective - a qualitative analysis of posts from the Samter’s Society;Alanin;Rhinology,2020

3. Survey-defined patient experiences with aspirin-exacerbated respiratory disease;Ta;J Allergy Clin Immunol Pract,2015

4. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (Liberty NP SINUS-24 and Liberty NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials;Bachert;Lancet,2019

5. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials;Gevaert;J Allergy Clin Immunol,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL‐4/IL‐13 pathway in nasal type 2 inflammation: The central role and targeted therapy;Eye & ENT Research;2024-01-12

2. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

3. Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease;The Journal of Immunology;2023-10-23

4. Allergy and Asthma Prevalence and Management Across Nasal Polyp Subtypes;Otolaryngologic Clinics of North America;2023-10

5. Aspirin-exacerbated respiratory disease;Annals of Allergy, Asthma & Immunology;2023-09